HopeStage
Back to all studies
RecruitingNCT05813093

Interleaved TMS and fMRI during accelerated iTBS for highly treatment-resistant depression

About this titleRead the official source — NCT05813093
Device studyAges 20–65Canada
The study in practice

Understand this study

Who could participate?

Listed age limits: 20 years to 65 years.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 27, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
88
Sponsor
Sunnybrook Health Sciences Centre
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
Canada
Age range
From 20 Years to 65 Years
Official registry ID
NCT05813093
Official title
Show the full official title

Interleaved TMS-fMRI to Evaluate Intermittent Theta-burst and Dorsolateral Prefrontal Circuit Engagement in Ultra-treatment Resistant Depression

Recruitment & locations

Currently recruiting

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sunnybrook Health Sciences Centre.

Who can participate?

Listed age limits: 20 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies